Rapid intrahepatic and peripheral blood HCV RNA decline and HCV-specific immune response increase during IFN-free DAA therapy in HCV treatment-naive patients

被引：0
|
作者：
MacParland, Sonya A. [1 ,2 ]
Cherepanov, Vera [1 ,2 ]
Vijgen, Leen [4 ]
Gamil, Mohamed [4 ]
Beumont, Maria [4 ]
Yoon, Sharon [1 ]
Rahman, A. K. M. Nur-Ur [1 ]
Aquino, Analiza [5 ]
Capraru, Camelia [2 ]
Brahmania, Mayur [1 ]
Ostrowski, Mario [1 ]
Wong, David K. [2 ]
Janssen, Harry L. [2 ]
Sulkowski, Mark S. [3 ]
Feid, Jordan J. [1 ,2 ]
机构：
[1] Univ Toronto, Toronto, ON, Canada
[2] McLaughlin Rotman Ctr Global Hlth, Toronto Ctr Liver Dis, Toronto, ON, Canada
[3] Johns Hopkins Univ, Sch Med, Bethesda, MD USA
[4] Janssen Infect Dis BVBA, Beerse, Belgium
[5] Mt Sinai Hosp, Toronto, ON, Canada
来源：
HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1465
引用
收藏
页码：732A / 732A
页数：1
相关论文
共 50 条
  • [31] IFN-free therapy is associated with restoration of type I IFN response in HIV-1 patients with acute HCV infection who achieve SVR
    Carlton-Smith, C.
    Holmes, J. A.
    Naggie, S.
    Lidofsky, A.
    Lauer, G. M.
    Kim, A. Y.
    Chung, R. T.
    JOURNAL OF VIRAL HEPATITIS, 2018, 25 (05) : 465 - 472
  • [32] Rapid and early virologic response to Cepeginterferon-alfa-2b in combination with ribavirine in treatment-naive patients with chronic HCV
    Znoyko, Olga
    Maevskaya, Marina V.
    Klimova, Elena
    Kizhlo, Svetlana
    Petrochenkova, Natalja
    Maximov, Semen
    Nagimova, Firaja
    Ivanov, Roman
    Linkova, Yulia
    Chernovskaya, Tatiana
    HEPATOLOGY, 2012, 56 : 586A - 586A
  • [33] Presence of HCV RNA in peripheral blood mononuclear cells may predict patients' response to interferon and ribavirin therapy
    Zaman, Nasib
    Asad, Muhammad Javaid
    Raza, Abida
    Raja, Ghazala Kaukab
    Akhter, Shamim
    Mahmood, Majid
    Mahmood, Raja Tahir
    ANNALS OF SAUDI MEDICINE, 2014, 34 (05) : 401 - 406
  • [34] Valopicitabine (NM283) plus PEG-interferon in treatment-naive hepatitis C patients with HCV genotype-1 infection: HCV RNA clearance during 24 weeks of treatment
    Lawitz, Eric
    Nguyen, Tuan
    Younes, Ziad
    Santoro, John
    Gitlin, Norman
    McEniry, David
    Chasen, Richard
    Goff, John
    Knox, Steven
    Kleber, Kristin
    Belanger, Bruce
    Brown, Nathaniel A.
    Dieterich, Douglas
    HEPATOLOGY, 2006, 44 (04) : 223A - 223A
  • [35] Clearance of HCV RNA in peripheral blood mononuclear cell as a predictor of response to antiviral therapy in patients with chronic hepatitis C
    Dao-Zhen Xu
    Hepatobiliary & Pancreatic Diseases International, 2005, (04) : 550 - 553
  • [36] Impact of IFN-Free and IFN-Based Treatment on Blood Myeloid Dendritic Cell, Monocyte, Slan-DC, and Activated T Lymphocyte Dynamics during HCV Infection
    Vita, Serena
    Zuccal, Paola
    Savinelli, Stefano
    Mascia, Claudia
    Rossi, Raffaella
    Schiavone, Francesco
    Marocco, Raffaella
    Tieghi, Tiziana
    Iannetta, Marco
    Nijhawan, Parni
    Zingaropoli, Maria Antonella
    d'Ettore, Gabriella
    Vullo, Vincenzo
    Mastroianni, Claudio Maria
    Lichtner, Miriam
    JOURNAL OF IMMUNOLOGY RESEARCH, 2020, 2020
  • [37] Efficacy and safety of IFN-free, DAA-based treatment-regimens in patients with HCV-recurrence after Liver Transplantation: Real-life experience from Austria
    Beinhardt, Sandra
    Al Zoairy, Ramona
    Freissmuth, Clarissa
    Kozbial, Karin
    Hametner, Stephanie
    Stern, Rafael
    Stauber, Rudolf E.
    Maieron, Andreas
    Staufer, Katharina
    Strasser, Michael P.
    Zoller, Heinz M.
    Graziadei, Ivo
    Vogel, Wolfgang
    Peck-Radosavljevic, Markus
    Trauner, Michael
    Ferenci, Peter
    Hofer, Harald
    HEPATOLOGY, 2015, 62 : 746A - 747A
  • [38] IMPROVEMENT OF LIVER FUNCTIONAL RESERVE AFTER SVR IN HCV-PATIENTS WITH COMPENSATED, SEVERE FIBROSIS BY IFN-FREE, DAA COMBINATION TREATMENT-IMPACT OF PRETREATMENT SERUM AFP LEVELS
    Ishigami, Masatoshi
    Honda, Takashi
    Ishizu, Yoji
    Imai, Norihiro
    Ito, Takanori
    Yamamoto, Kenta
    Fujishiro, Mitsuhiro
    HEPATOLOGY, 2020, 72 : 564A - 565A
  • [39] Hepatitis C virus (HCV) RNA in plasma and not peripheral blood mononuclear cells (PBMC) is comparable to hepatic HCV RNA when obtained while on therapy at the end of treatment as a predictor of sustained response in patients with chronic hepatitis C infection.
    DeGuzman, LJ
    Neito, JM
    Conrad, A
    Calip, C
    Schmidt, WN
    HEPATOLOGY, 2000, 32 (04) : 354A - 354A
  • [40] Liver injury and changes in hepatitis C virus (HCV) RNA load associated with protease inhibitor-based antiretroviral therapy for treatment-naive HCV-HIV-coinfected patients: Lopinavir-ritonavir versus nelfinavir
    Sherman, KE
    Shire, NJ
    Cernohous, P
    Rouster, SD
    Omachi, JH
    Brun, S
    Da Silva, B
    CLINICAL INFECTIOUS DISEASES, 2005, 41 (08) : 1186 - 1195
12345